Hiramuki, Yosuke
Abe, Satoshi
Uno, Narumi
Kazuki, Kanako
Takata, Shuta
Miyamoto, Hitomaru
Takayama, Haruka
Morimoto, Kayoko
Takehara, Shoko
Osaki, Mitsuhiko
Tanihata, Jun
Takeda, Shin’ichi
Tomizuka, Kazuma
Oshimura, Mitsuo
Kazuki, Yasuhiro
Funding for this research was provided by:
Science and Technology Platform Program for Advanced Biological Medicine from AMED (JP22am0401002)
JST, CREST (JPMJCR18S4)
Research Support Project for Life Science and Drug Discovery (BINDS) from AMED (JP22ama121046)
Joint Research of the Exploratory Research Center on Life and Living Systems (21-101)
Article History
Received: 1 December 2022
Accepted: 13 March 2023
First Online: 16 March 2023
Competing interests
: M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and S.A., H.T., K.M., and S. Takehara are employees of Trans Chromosomics, Inc. The remaining authors declare no conflicts of interest.